Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001810842 | SCV001477911 | uncertain significance | not provided | 2020-06-04 | criteria provided, single submitter | clinical testing | The G6PD c.108_110delCAT; p.Ile36del variant (rs137852338), also known as G6PD Sunderland or p.Ile66del on NM_000402.4, is reported in the literature in the hemizygous state in an individual affected with G6PD deficiency and chronic hemolytic anemia (MacDonald 1991). This variant deletes a single isoleucine residue leaving the rest of the protein in-frame. This variant is reported in ClinVar (Variation ID: 10400), and is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. However, given the lack of clinical and functional data, the significance of the p.Ile36del variant is uncertain at this time. References: MacDonald D et al. Deficiency in red blood cells. Nature. 1991;350(6314):115. References: MacDonald D et al. Deficiency in red blood cells. Nature. 1991;350(6314):115. |
Dunham Lab, |
RCV000011141 | SCV002599161 | likely pathogenic | Anemia, nonspherocytic hemolytic, due to G6PD deficiency | 2022-08-12 | criteria provided, single submitter | curation | Variant found in hemizygote with G6PD deficiency and CNSHA (PP4). Decreased activity in red blood cells of hemizygote (PS3). Leads to deletion of one amino acid (PM4) and is not observed in gnomAD (PM2). Post_P 0.989 (odds of pathogenicity 729.3, Prior_P 0.1). |
OMIM | RCV000011140 | SCV000031367 | other | G6PD SUNDERLAND | 2013-10-24 | no assertion criteria provided | literature only |